KLAS

Health Tech

Debunking 4 Misbeliefs About Why Vendors Keep Breaking Promises to Providers

One in four providers said that health technology vendors haven’t kept their promises in the past year. KLAS Research debunked four common misconceptions vendors may have about why so many providers feel this way — such as the false notion that employees who weren't part of the purchasing decision feel the most disappointed by vendors or the misbelief that it's better to not make promises in the first place.

presented by
Health Tech

7 Rules Hospitals Should Follow When Adopting New Tech

Hospitals’ operational margins have shrunk dramatically this year. Now more than ever, hospitals need to ensure they’re getting the most out of their investments in technology. Clear governance structures, effective communication and detailed training are among the factors hospitals need in order to get a significant return on investment for technology deployments, according to a new report.

Health Tech

Report: What is helping AWS beat its health cloud competitors

AWS may be emerging as the healthcare sector’s cloud darling, as healthcare customers are reporting high levels of satisfaction and large health systems are beginning to ink long-term cloud partnership plans. Healthcare organizations that choose AWS over its competitors do so because they believe it’s the most mature and healthcare-focused cloud platform, according to a KLAS report released Tuesday.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.